{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:26:24Z","timestamp":1791332784215,"version":"4.3.1"},"reference-count":59,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201000005I"],"award-info":[{"award-number":["HHSN272201000005I"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pathsocjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pathology"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Persistent or dysregulated\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013 responses are key drivers of fibrosis in multiple organ systems, and this identifies this cytokine as an important therapeutic target. Nevertheless, the mechanisms by which\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013 blockade leads to the amelioration of fibrosis remain unclear. Because\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 exhibits potent anti\u2010fibrotic activity, and\n                    <jats:styled-content style=\"fixed-case\">IL\u20104R\u03b1<\/jats:styled-content>\n                    signalling antagonizes\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 effector function, compensatory increases in\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 activity following\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013\/\n                    <jats:styled-content style=\"fixed-case\">IL\u20104R\u03b1<\/jats:styled-content>\n                    blockade might contribute to the reduction in fibrosis. To investigate the role of\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3, we developed novel\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    \/\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    double cytokine\u2010deficient mice and examined disease progression in models of type 2\u2010driven fibrosis. As predicted, we showed that fibrosis in the lung and liver are both highly dependent on\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013. We also observed increased\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 production and inflammatory activity in the tissues of\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013\u2010deficient mice. Surprisingly, however, an even greater reduction in fibrosis was observed in\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013\/\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 double deficient mice, most notably in the livers of mice chronically infected with\n                    <jats:italic>Schistosoma mansoni<\/jats:italic>\n                    . The increased protection was associated with marked decreases in\n                    <jats:italic>Tgfb1<\/jats:italic>\n                    ,\n                    <jats:italic>Mmp12<\/jats:italic>\n                    , and\n                    <jats:italic>Timp1<\/jats:italic>\n                    <jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>\n                    expression in the tissues; reduced inflammation; and decreased expression of important pro\u2010inflammatory mediators such as\n                    <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\n                    \u2010\u03b1. Experiments conducted with neutralizing monoclonal antibodies to\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013 and\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 validated the findings with the genetically deficient mice. Together, these studies demonstrate that the reduction in fibrosis observed when\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013 signalling is suppressed is not dependent on increased\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 activity. Instead, by reducing compensatory increases in type 1\u2010associated inflammation, therapeutic strategies that block\n                    <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                    \u2010\u03b3 and\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013 activity simultaneously can confer greater protection from progressive fibrosis than\n                    <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                    \u201013 blockade alone. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.\n                  <\/jats:p>","DOI":"10.1002\/path.4733","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T09:04:34Z","timestamp":1462007074000},"page":"344-354","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Enhanced protection from fibrosis and inflammation in the combined absence of IL\u201013 and\n                    <scp>IFN<\/scp>\n                    \u2010\u03b3"],"prefix":"10.1002","volume":"239","author":[{"given":"Thirumalai R","family":"Ramalingam","sequence":"first","affiliation":[{"name":"Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L","family":"Gieseck","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Acciani","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"M Hart","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen W","family":"Cheever","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M","family":"Mentink\u2010Kane","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute  Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M","family":"Vannella","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A","family":"Wynn","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3831"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3494"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aab3142"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11047"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3476"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3427"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3349"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.10.1565"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5397.2258"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002003"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1117"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2277"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206719"},{"key":"e_1_2_7_16_1","first-page":"145","article-title":"Lebrikizumab idiopathic pulmonary fiborsis trial: phase II randomized, double\u2010blind, placebo controlled study to assess efficacy and safety (RIFF)","volume":"19","author":"Scalori A","year":"2014","journal-title":"Respirology"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7325"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.34"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(24)35380-7","article-title":"Interleukin\u201013 modulates collagen homeostasis in human skin and keloid fibroblasts","volume":"292","author":"Oriente A","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/01902149509050842"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.2.920"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.5.2585"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26376"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.5.1551"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0354-4"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004709200"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.6.4020"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.12.7017"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903008"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6406"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3023"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.1.337"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06878"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020903"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106469"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301761"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0342OC"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.12.040194.003223"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.5.2.1825981"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.1_suppl.S5"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1412"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.20.10663"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/376594a0"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030511"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/362248a0"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.12.7151"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-475X.1999.00442.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-010-9180-8"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.2.1295"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.4.1992"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2004.00195.x"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1086\/302526"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.2.929"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.6.3391-3397.2004"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.1.159"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2617"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2678"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-816"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/359693a0"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/29814"}],"container-title":["The Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpath.4733","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/path.4733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:34:08Z","timestamp":1760956448000},"score":1,"resource":{"primary":{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/10.1002\/path.4733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1002\/path.4733"],"URL":"https:\/\/doi.org\/10.1002\/path.4733","archive":["Portico"],"relation":{},"ISSN":["0022-3417","1096-9896"],"issn-type":[{"value":"0022-3417","type":"print"},{"value":"1096-9896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]},"assertion":[{"value":"2015-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}